
Aspire Awards 2026
The 2026 Business Events Perth Aspire Award recipients have been announced at Perth Convention and Exhibition Centre today. Ten Western...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Research groups
Dr Aleksandra Miljevic is an emerging clinical neuroscience researcher specialising in youth depression, brain connectivity and non-invasive brain stimulation. She is a Research Fellow within the Brain Plasticity Research Group at the Perron Institute, manages the Perron rTMS Clinic and is a lead coordinator of the WA TMS Network.
Dr Miljevic completed her PhD at Monash University in 2024, investigating rigorous methods for measuring electroencephalography (EEG) functional connectivity in people with depression. Her research examined how methodological differences shape the interpretation of communication between brain regions and influence the identification and predictive value of neurophysiological biomarkers for brain-related disorders and treatment response.
Her current work combines clinical trials, genetics, magnetic resonance imaging, EEG and repetitive transcranial magnetic stimulation (rTMS) to advance personalised mental healthcare. She has contributed to studies of antidepressant pharmacogenetics and real-world rTMS outcomes in young Western Australians.
Dr Miljevic has secured an FHRI Translational Fellowship to investigate brain stimulation and genetic screening for youth suicide ideation, alongside funding supporting paediatric neuroimaging and pharmacogenetic research. Through the Perron rTMS Clinic, her research is integrated with treatment for young people experiencing depression and other psychiatric conditions.
Working across neuroscience, psychiatry, and clinical care, Dr Miljevic is building the evidence base for safe, non-pharmacological treatments for youth. Her work brings together young people, clinicians and community organisations, aiming to provide better treatment choices and more precise pathways towards recovery.
Keep informed with our latest updates.
Stay up to date with our latest news and announcements.